Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

NCT03159897

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1 Padova, Italy

Ospedale delle Croci - Ematologia Ravenna, Italy

A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia Alessandria, Italy

Università Politecnica delle Marche, Clinica di Ematologia Ancona, Italy

View all 46 locations

View Trial Details

Completed

Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE

NCT06535997

Conditions: Adenocarcinoma, Angiosarcomas, Cancer, +29 more
Locations: Centre François Baclesse, Centre de lutte contre le cancer (CLCC) Caen, France

Hôpital Michallon, CHU de Grenoble-Alpes Grenoble, France

View Trial Details

Completed

Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia

NCT03957915

Conditions: Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia, in Relapse, Acute Myeloid Leukaemia Recurrent, +16 more
Locations: Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France

Chu Bordeaux Hopital Haut Leveque Pessac, France

IUCT Toulouse, France

View Trial Details

Completed

Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

NCT03739619

Conditions: Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Emory Saint Joseph's Hospital Atlanta, Georgia, United States

View Trial Details

Completed

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

NCT02793544

Conditions: Acute Biphenotypic Leukemia (ABL), Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma, Acute Myelogenous Leukemia (AML), +26 more
Locations: Shands HealthCare & University of Florida Gainesville, Florida, United States

University of Miami Miami, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

NCT03331341

Conditions: Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +7 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

NCT00049595

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Canberra Hospital Garran, Australian Capital Territory, Australia

Nepean Cancer Care Centre at Nepean Hospital Kingswood, New South Wales, Australia

Westmead Institute for Cancer Research at Westmead Hospital Westmead, New South Wales, Australia

Princess Alexandra Hospital Brisbane, Queensland, Australia

View all 140 locations

View Trial Details

Completed

Phase I Trial of GR1803 Injection in Patients With RRMM

NCT07102706

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Completed

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

NCT04194840

Conditions: Allogeneic and Autologous Stem Cell Transplant, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

A Study to Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT07103486

Conditions: Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Novartis East Hanover, New Jersey, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions